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Fig. 1. Mathematical model and FRL controller in simulink environment.
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Extended Abstract
Introduction: Chronic myelogenous (CML) is a cancer of the
blood, and accounts for about 15% of all leukemia cases in adults.
The median age for patients emerging CML is between 45 and 55
years, and one or two cases occur per 100000 people per year.
Knowledge of Bcr-Abl as an abnormal tyrosine kinase protein has
led to the invention of imatinib mesylate (known as Gleevec in
the U.S. and henceforth mentioned to as imatinib). Prior to the
development of imatinib, the most common chemotherapies used
to treat CML included interferon-alpha, cytarabine and hydrox-
yurea, sometimes in combination. In this paper, we apply fuzzy
reinforcement learning as a free model optimal controller to a
CML model with a molecular targeted therapy (such as imatinib),
and a broad cytotoxic chemotherapy (such as cytarabine). Our
goal in this study is to minimize the cancer cell population and
the disadvantageous effects of the two types of drugs to the body
of a hypothetical individual. The action of these therapies is against
broad classes of cells, and so treatment usually results in severe side
effects. Several studies suggest that combination of imatinib with a
broader chemotherapy has the potential to perform better than
alone.
Fuzzy inference systems offer robust and smooth response.
However, they do involve the existence of an expert to define the
suitable rule-set. The main challenge is, therefore, to be able to
make the appropriate rule-set without the existence of a direct
trainer. Studies have been carried out to design fuzzy logic based
controllers without the need of an expert’s experience and informa-
tion. To solve this issue Raju et al. proposed a fuzzy controller with
the fuzzy sliding surface. Shao and Shihuang studied a fuzzy self-
organizing controller, where the control policy is able to develop
and improve by itself. Reinforcement learning (RL) can also be
practical in this situation, to drive the generation of the suitable
rule-set based on the interactions with the environment. It can be
simply combined with fuzzy logic and provide the relationship
between the states and the admissible action, which is the same
as creating the fuzzy logic “if…then” engine. In this paper the
approach of reinforcement learning is conducted toward having a
real controller for reducing cancer cell population by using two dif-
ferent drugs dosages.
The rest of the paper was organized as follows. First of all the
fuzzy reinforcement learning principles were considered. Then, math-
ematical model of cancer was introduced. Afterwards, this model was
simulated in the MATLAB-SIMULINK environment. In the simula-
tion section, the controller was implemented to the model. Finally,
a comprehensive discussion concludes the paper.
Fuzzy-reinforcement learning strategy: Reinforcement Learn-
ing is a powerful tool for finding the optimum policy for a certain
process. RL utilizes the environment feedback and produces a signalnamed reinforcement. This signal might be a reward or a punishment.
In an analogy to control systems, agent plays a same role as the proc-
ess and action is as the controller signal. RL intention is to find the
best action for each state which agent (process) wants to move to.
Q-Learning is a simple algorithm which is used in this paper. This
algorithm has a lookup table named Q table. It tries to estimate the
discounted future rewards for taking actions from given states. This
method is either impracticable in the case of large state-actions
spaces, or impossible with continuous state spaces. Many studies pro-
posed methods for approximating the Q table, these methods are not
totally desirable because of their slow solution. Another approach is
to integrate fuzzy sets and reinforcement learning together. In this
case, all of states are the same as the inputs of fuzzy and action is
defined as the output. Algorithm 1 shows the Q-Learning reinforce-
ment learning principals with their equations. In this method,
Takagi-Sugeno FIS is used and all of rules are between input mem-
bership functions, moreover, the constant outputs are tuned by
Q-Learning.
- Observe the state x
- For each rule: choose the actual consequence using greedy or
epsilon-greedy
- Compute the global consequence a(x) and its corresponding
Q-value Q(x, a) by EQ. (2)
- Apply the action a(x) by EQ. (1). Let y be the new state
- Receive the reinforcement r
- Update Q-values by EQ3.(3-5)
Alg1. Q-Learning Reinforcement Learning Principals
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In these equations, a is the learning rate, a is the action series, r is
reinforcement, g is discount rate and ai is the truth value. The param-
eters mentioned in this algorithm are arbitrary and select by trial and
error.
Modeling and simulation: The proposed mathematical model
for cancer cells are employed from the research of Moore and Li
Fig. 2. Drug dosage policy determined from FRL algorithm.
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tions are considered to show the growth of can cell population ver-
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The proposed model was simulated in Simulink environment,
where the fuzzy reinforcement learning controller is used. As shown
in Figure 1, two controllers evaluated the dosage of drugs. After
many iterations, fuzzy reinforcement learning presented a policy
used for therapy as shown in Figure 2. By using this policy, the trend
of drug dosage is shown in Figure 3. As illustrated in this graph, the
dosage of the first drug, imatinib and the second one, cytarabine is
decreased. It means the side effect of the drug considered in low
level. Nevertheless, the cell population number is decreeing in
Figure 4.
Conclusion: In this paper, a new free model based fuzzy rein-
forcement learning is introduced to meet the challenges of differ-
ent patient conditions. In this method, a controller system is
learned by some trial systematic therapies and finally make known
to an expert therapist machine which can set the drug dosage for
the proposed patient. Instead of a real patient, we used a mathe-
matical model which determined the population of cancer cell
for an special patient. By simulating the model in MATLAB-
SIMULINK environment and employing the revealed controller,
the achieved results show a reliably control by decreasing side
effects.
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control, Mathematical model of cancer cellFig. 3. Drug dosage used for the proposed patient.
Fig. 4. Cancer population control versus time using FRL algorithm.
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Extended Abstract
Introduction: Breast cancer is the most frequent cancer and sec-
ond most common cause of cancer related death in women world-
wide. Although breast cancer is not a lethal cancer by self,
metastasis to distant organs is the main cause of breast cancer mortal-
ity and is associated with poor prognosis in breast cancer patients.
Spreading of tumor to auxiliary lymph node is one of the most impor-
tant factors predicting metastasis of tumor cells. Conventional thera-
peutic strategies include assessment of local lymph node involvement1 Atieh Eslahi, Mahdieh Daliri Ghouchan Atigh contributed equally to this
work.
